BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 2 |
iShares US Financials ETF
IYF
|
+$119M |
| 3 |
AGN
Allergan plc
AGN
|
+$100M |
| 4 |
Charter Communications
CHTR
|
+$95.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$82.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$909M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.73% |
| 2 | Financials | 5.47% |
| 3 | Healthcare | 4.96% |
| 4 | Consumer Discretionary | 4.64% |
| 5 | Industrials | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Global X MLP ETF
MLPA
$2.28B
| $93.7K | ﹤0.01% |
1,981
+707
| +55% | +$33K |
|
|
ACR
3202
ACRES Commercial Realty
ACR
$101M
| $93.5K | ﹤0.01% |
2,638
+1,021
| +63% | +$35.8K |
|
|
COWN
3203
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $93.4K | ﹤0.01% |
5,933
+1,480
| +33% | +$22.2K |
|
3204
Old Second Bancorp
OSBC
$1.31B
| $93.4K | ﹤0.01% |
6,936
+2,300
| +50% | +$28.7K |
|
3205
Palomar
PLMR
$3.37B
| $93.2K | ﹤0.01% |
1,845
+1,129
| +158% | +$52.9K |
|
|
MDR
3206
DELISTED
McDermott International
MDR
| $92.5K | ﹤0.01% |
136,722
+87,608
| +178% | +$112K |
|
|
UMH
3207
UMH Properties
UMH
$1.42B
| $92.3K | ﹤0.01% |
5,868
+426
| +8% | +$6.42K |
|
|
VRTV
3208
DELISTED
VERITIV CORPORATION
VRTV
| $92.2K | ﹤0.01% |
4,686
+2,787
| +147% | +$48.6K |
|
3209
NextCure
NXTC
$37.9M
| $92K | ﹤0.01% |
136
+124
| +1,033% | +$62.2K |
|
|
DSSI
3210
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
| $91.9K | ﹤0.01% |
5,489
+2,712
| +98% | +$40.5K |
|
|
HTB
3211
HomeTrust Bancshares
HTB
$837M
| $91.7K | ﹤0.01% |
3,419
+761
| +29% | +$20K |
|
|
ANH
3212
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $91K | ﹤0.01% |
25,855
+8,058
| +45% | +$27.9K |
|
3213
American Coastal Insurance
ACIC
$461M
| $90.9K | ﹤0.01% |
7,211
+3,909
| +118% | +$49.7K |
|
|
TRUE
3214
DELISTED
TrueCar
TRUE
| $90.9K | ﹤0.01% |
19,129
+1,382
| +8% | +$5.77K |
|
3215
West Bancorporation
WTBA
$511M
| $90.7K | ﹤0.01% |
3,538
+966
| +38% | +$23K |
|
3216
Petrobras Class A
PBR.A
$104B
| $90.3K | ﹤0.01% |
6,050
-106,072
| -95% | -$1.5M |
|
3217
Vericel Corp
VCEL
$2.28B
| $90.3K | ﹤0.01% |
5,187
-1,753
| -25% | -$29.8K |
|
3218
CPI Aerostructures
CVU
$75M
| $89.7K | ﹤0.01% |
+13,332
| New | +$98.1K |
|
|
XENT
3219
DELISTED
Intersect ENT, Inc
XENT
| $89.5K | ﹤0.01% |
3,593
-1,203
| -25% | -$24.4K |
|
3220
Teekay
TK
$1.06B
| $89.2K | ﹤0.01% |
16,765
+5,591
| +50% | +$27.7K |
|
|
ATRS
3221
DELISTED
Antares Pharma, Inc.
ATRS
| $89.1K | ﹤0.01% |
18,951
-4,868
| -20% | -$19.9K |
|
|
WAAS
3222
DELISTED
AquaVenture Holdings Limited
WAAS
| $89K | ﹤0.01% |
3,283
+1,496
| +84% | +$31.7K |
|
3223
Univest Financial
UVSP
$1.19B
| $89K | ﹤0.01% |
3,324
-1,258
| -27% | -$32.6K |
|
|
DPLO
3224
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $88.6K | ﹤0.01% |
22,156
+11,751
| +113% | +$55.2K |
|
|
CEO
3225
DELISTED
CNOOC Limited
CEO
| $88.3K | ﹤0.01% |
530
+70
| +15% | +$10.7K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2019 Portfolio in Review
As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.3% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.
- BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
- BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
- BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
- BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
- BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.